Rhode Island House Bill H7172

Rhode Island 2026 Regular Session

• Introduced: 1/21/26
• Refer: 1/21/26

Caption

Creates and establishes the Health Care and Social Services Transaction Review and Significant Equity Investor Disclosure Act designed to enhance disclosure for material changes involving significant equity investors.

Impact

If enacted, HB 7172 will require significant equity investors involved in material changes within covered care entities to notify the Department of Health and the Attorney General’s office at least 60 days prior to any significant transaction. This notification must include detailed information about the transaction, the involved parties, and the post-transaction governance structure. Furthermore, the bill empowers state agencies to mandate additional disclosures and can impose civil penalties for non-compliance, which emphasizes the state’s commitment to monitoring the potential impacts of these changes on service availability and workforce stability.

Summary

House Bill 7172, known as the Health Care and Social Services Transaction Review and Significant Equity Investor Disclosure Act, is designed to enhance transparency and public interest protections in health care and social services. The bill arises out of growing concerns regarding the influence of private equity and significant equity investors over organizations that provide essential services to the population. With the intent to safeguard cost, access, and quality of care, the bill establishes mandates for disclosure regarding any changes in control or ownership of covered care entities.

Contention

The discussions around HB 7172 may evoke contention, particularly regarding the balance between investor interests and the need for public safeguarding in health care. Proponents argue that increased transparency will protect consumers and ensure that providers remain accountable in the face of changing ownership. On the other hand, critics may view these requirements as potentially burdensome for investors and entities involved in healthcare services. Additionally, there is a potential concern about confidentiality and the handling of sensitive financial information, as while the bill aims for public transparency, it provides for the protection of confidential commercial information when necessary.